EAM Investors’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,101
Closed -$616K 313
2024
Q1
$616K Buy
+12,101
New +$616K 0.1% 227